OCT 01, 2015 09:00 AM PDT
Engaging the Patient in the Treatment Journey
Presented at the Cancer Research and Oncology Virtual Event
2 14 726

Speakers:
  • Executive Director, Melanoma Research Foundation
    Biography
      Tim Turnham became the Executive Director of the Melanoma Research Foundation (MRF) in January 2009. Tim shares the MRF's commitment to supporting medical research to find more effective treatments and eventually a cure for melanoma and brings more than 30 years of experience in management, fundraising, communication, teaching and research.

      Prior to joining the MRF, Tim served as Chief Executive Officer of the Colon Cancer Alliance as well as Director of Development for United Cerebral Palsy Associations. He has also served as the Director of Development for the Whitman-Walker Clinic and as Director of Development at the Children's Research Institute.

      Tim holds a B.A. in Microbiology from the University of Tennessee, a M. Div. from the New Orleans Baptist Theological Seminary and a Ph.D. from the Southern Baptist Theological Seminary.

      Tim lives in Washington, D.C. with his wife Phyllis. They have three adult children
    • Director of Education, Melanoma Research Foundation
      Biography
        Shelby Moneer joined the MRF team in August of 2010 to oversee the education program. As the Director of Education, Shelby is responsible for all development, implementation and assessment of the education program. This includes patient/caregiver education, clinician education, primary and secondary prevention efforts, print materials, awareness campaigns, website content, over-the-phone patient navigation and all patient resources and communication. These programs range from in-person events, virtual events and include a wide variety of print materials, all of which are free to the public. Shelby is also the manager of the MRF's research grant program.

        Shelby holds a bachelor's degree in Exercise Science and a master's degree in Health Education. Her previous experience was in the non-profit development, implementation and assessment of tobacco-related education, prevention and treatment strategies in the Florida Panhandle. She was a collegiate volleyball and softball player and continues playing beach volleyball whenever she can. Shelby and her husband, Steve, have a 3 year old daughter and live in Spokane, WA. They enjoy playing and watching sports, spending time outdoors and being surrounded with friends and family.

      Abstract:
      This is an exciting time for melanoma treatment, with a half-dozen new drugs approved in just over four years. This influx has brought a new complexity to the field, however, including questions about which drugs to give which patients, in what order to give those drugs, and in what combination they can be given. The rapid rise of immunotherapy drugs has introduced a new type of side effect profile that further complicates treatment. One overlooked result of these changes is the need for a new level of communication between patients and their health care team. Data is clear that patients who are well informed and well supported live longer and better, but what does that look like in the current treatment landscape.
       

      Show Resources
      Loading Comments...